In one paragraphArticle in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Anna Esteve-GarciaClinical Genetics Unit, Metropolitan South Clinical Laboratory, Bellvitge University Hospital, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-6005-2756 Cristina SauClinical Genetics Unit, Metropolitan South Clinical Laboratory, Bellvitge University Hospital, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0009-0003-3687-1406 Ariadna Padró-MiquelGenetics Laboratory, Metropolitan South Clinical Laboratory, Bellvitge University Hospital, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-6488-447X Jaume Català-MoraDepartment of Ophthalmology, SJD Barcelona Children's Hospital, Esplugues de Llobregat, 08950 Barcelona, Spain.ORCID 0000-0003-2152-8579 Cinthia AguileraGenetics Laboratory, Metropolitan South Clinical Laboratory, Bellvitge University Hospital, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Estefania CobosThe Hereditary Retinal Dystrophies Unit, Ophthalmology Departments at SJD Barcelona Children's Hospital and University Hospital of Bellvitge, 08950 Barcelona, Spain.ORCID 0000-0001-8343-1313 Funding
Bellvitge University Hospital PUB22015
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antigens, NeoplasmCell Cycle ProteinsCytoskeletal ProteinsPhenotypeRetinal DystrophiesExome SequencingFemaleFrameshift MutationHumansMaleMutation, MissensePedigreeSiblingsAntigens, NeoplasmCell Cycle ProteinsCep290 protein, humanCytoskeletal ProteinsCEP290phenotypic heterogeneityretinal dystrophy
Identifiers
PMID39766851
PMCPMC11675463
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390